Home / Posaconazole / United States
US ATC J02AC04 · updated 2 Nov 2026
Posaconazole shortage in United States
Is there a Posaconazole shortage in United States?
Yes. As of 2 Nov 2026, 1 Posaconazole product is reported short in United States, the first since 2 Dec 2025. No return date has been given. Main reason: not stated.
Also short in Canada, Italy, Czechia, Norway, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Noxafil, Injection, 18 mg/1 mL (NDC 0085-4331-01) discontinuation | Merck Sharp & Dohme Corp. | 2 Dec 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).